NAUT
Nautilus Biotechnology Inc
NASDAQ: NAUT · HEALTHCARE · BIOTECHNOLOGY
$2.50
-3.47% today
Updated 2026-04-29
Market cap
$317.70M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$1 – $4
Volume
0.3M
Nautilus Biotechnology Inc (NAUT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-32.30%
ROA
-19.30%
Debt/equity
0.16x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $626.60M | — | — | — |
| 2019 | — | $-9.62M | — | — | — |
| 2020 | $0.00 | $-15.62M | — | — | — |
| 2021 | $0.00 | $-50.31M | — | — | — |
| 2022 | $0.00 | $-57.92M | — | — | — |
| 2023 | $0.00 | $-63.67M | — | — | — |
| 2024 | $0.00 | $-70.78M | — | — | — |
| 2025 | $0.00 | $-59.00M | — | — | — |